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Introduction
The visceral leishmaniosis (VL), or Calazar, is a chronic
severe systemic disease, potentially fatal to humans.
Currently, VL is the prototype of a specific immune
dysfunction resulting from parasitism of leishmania
donovani in macrophages, producing a broad spectrum
of clinical and immunological reversible only with specific
treatment. Serum Analysis from infected adult patients
demonstrated the presence of autoantibodies against
cellular and humoral components, and circulating
immune complexes.
Objectives
To identify the profile of autoantibodies in pediatric
patients with VL and its correlation with clinical outcome.
Methods
Through a transversal study, was investigated the occur-
ence of autoantibodies ( antinuclear antibodies (ANA),
anti-DNA , anti-SM , anti-RNP , anti-SSb , anti-SSa, lupus
anticoagulant, IgG and IgM anticardiolipin (aCL)
antibodies) in 34 patients (under 18 years) with diagno-
sis of VL, at the beginning and shortly after treatment,
in the period October 2010 to March 2011.
Results
The incidence of autoantibodies present at the beginning
in patients with VL was 64,7% (10 with ANA positive
(29,4%), 7 with lupus anticoagulant antibodies positive
(20,58%), 8 with IgM aCL antibodies positive (23,5%) and
5 with IgG aCL antibodie positive (14,7%) and 1 with
Anti-RNP (2,9%). Sex, age, visceromegaly, nutritional
status, treatment, use of corticosteroids, infections, hemo-
phagocytic syndrome, febrile neutropenia, hemoglobin
level and platelet count parameters were correlated with
the presence of antibodies (table:1). It was found asso-
ciated anaemia (p<0,05) with the antibody presence, but
more studies are needed to evaluate the presence of hemo-
lytic anemia associated. Infections: sepsis, pneumonia and
urinary tract infection in 71,42% of total patients, but not
correlated with antibodies. Autoimmunity was greatly
reduced after treatment; the statistical significance
remained after stratification in ANA.
Conclusion
Visceral leishmaniasis appears to correlate positively with
the presence of ANA, lupus anticoagulant, IgG ang IgM
aCL, in children, as in adults possibly by triggering a
systemic humoral response of Th2. We found association
statistically significant with lower hemoglobin level in
these patients. Further studies are needed to evaluate the
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